| scholarly article | Q13442814 |
| P50 | author | Victoria Findlay | Q38523395 |
| P2093 | author name string | Chris Parsons | |
| Zhiqiang Qin | |||
| Andrew Jakymiw | |||
| P2860 | cites work | Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells | Q44761629 |
| LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma. | Q47684034 | ||
| Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells | Q47978435 | ||
| KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma | Q58907143 | ||
| Characterization of in vitro culture of HIV-negative Kaposi's sarcoma-derived cells. In vitro responses to alfa interferon | Q73567575 | ||
| Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions | Q74171859 | ||
| The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility | Q84470156 | ||
| MicroRNA biogenesis and cancer | Q85172584 | ||
| Identification of cellular genes targeted by KSHV-encoded microRNAs | Q21131610 | ||
| Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor | Q24301712 | ||
| The Microprocessor complex mediates the genesis of microRNAs | Q24312976 | ||
| Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells | Q24555724 | ||
| The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 | Q24617130 | ||
| Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice | Q24623247 | ||
| Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study | Q24643018 | ||
| Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver | Q24649633 | ||
| Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. | Q24651016 | ||
| A viral microRNA functions as an orthologue of cellular miR-155 | Q24652947 | ||
| Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF | Q24653834 | ||
| Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155 | Q24681400 | ||
| Silencing Viral MicroRNA as a Novel Antiviral Therapy? | Q27488437 | ||
| The functions of animal microRNAs | Q27860621 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
| Processing of primary microRNAs by the Microprocessor complex | Q27860986 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex | Q28243956 | ||
| Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 | Q28285980 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress | Q28472699 | ||
| miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA | Q28476790 | ||
| Intracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components | Q28757509 | ||
| Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 | ||
| Identification of microRNAs of the herpesvirus family | Q29618671 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
| Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster | Q29620726 | ||
| Silencing of microRNA families by seed-targeting tiny LNAs | Q36522844 | ||
| CpG island hypermethylation of tumor suppressor microRNAs in human cancer | Q36854202 | ||
| A microRNA DNA methylation signature for human cancer metastasis | Q36861111 | ||
| Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis | Q36882284 | ||
| The guardian's little helper: microRNAs in the p53 tumor suppressor network | Q37023130 | ||
| The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion | Q37033356 | ||
| Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection | Q37066263 | ||
| Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma | Q37237479 | ||
| Viral and cellular messenger RNA targets of viral microRNAs | Q37374202 | ||
| Immunological functions of hyaluronan and its receptors in the lymphatics | Q37548667 | ||
| Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs | Q38357974 | ||
| Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling | Q39673166 | ||
| MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta | Q39703169 | ||
| Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay | Q39711736 | ||
| KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming | Q39751014 | ||
| Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation | Q39763904 | ||
| Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
| Suppression of dendritic cell differentiation through cytokines released by Primary Effusion Lymphoma cells | Q39953809 | ||
| Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression | Q40002571 | ||
| Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. | Q40002946 | ||
| A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia | Q40106826 | ||
| Expression and function of microRNAs encoded by Kaposi's sarcoma-associated herpesvirus | Q40155119 | ||
| The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. | Q40169748 | ||
| Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease | Q40177470 | ||
| DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages | Q40327365 | ||
| Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. | Q40364647 | ||
| Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells | Q40749885 | ||
| Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions | Q42049779 | ||
| Prediction of human targets for viral-encoded microRNAs by thermodynamics and empirical constraints | Q42121608 | ||
| The magic and mystery of miR-21 | Q42396388 | ||
| Mono/oligoclonal pattern of Kaposi Sarcoma-associated herpesvirus (KSHV/HHV-8) episomes in primary effusion lymphoma cells | Q43890736 | ||
| High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. | Q44424254 | ||
| Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma | Q30418735 | ||
| Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM | Q33336561 | ||
| Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. | Q33432690 | ||
| In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery | Q33558454 | ||
| Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes | Q33571183 | ||
| Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA | Q33625562 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a | Q33753956 | ||
| Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model | Q33780722 | ||
| A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest | Q33826818 | ||
| Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus | Q33883910 | ||
| Morpholino antisense oligomers: the case for an RNase H-independent structural type | Q33901587 | ||
| Comprehensive analysis of human microRNA target networks | Q33935461 | ||
| Computational prediction of intronic microRNA targets using host gene expression reveals novel regulatory mechanisms | Q33939100 | ||
| Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy | Q34021322 | ||
| Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway | Q34092628 | ||
| Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study. | Q34101588 | ||
| miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. | Q34112056 | ||
| MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. | Q34166899 | ||
| Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression | Q34291063 | ||
| Transcriptional regulation of mammalian miRNA genes | Q34482425 | ||
| Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. | Q34507156 | ||
| A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses | Q34547697 | ||
| A novel assay for viral microRNA function identifies a single nucleotide polymorphism that affects Drosha processing | Q34648273 | ||
| Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. | Q34673364 | ||
| Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression | Q34742851 | ||
| Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes | Q34756351 | ||
| miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells | Q35001206 | ||
| Retinoic acid-inducible gene I-inducible miR-23b inhibits infections by minor group rhinoviruses through down-regulation of the very low density lipoprotein receptor | Q35111113 | ||
| A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice | Q35382266 | ||
| Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice | Q35673271 | ||
| A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε. | Q35885525 | ||
| Evidence for multiclonality in multicentric Kaposi's sarcoma | Q36173459 | ||
| The pleiotropic effects of Kaposi's sarcoma herpesvirus | Q36346099 | ||
| Kaposi's sarcoma and its associated herpesvirus | Q36487309 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 603961 | |
| P577 | publication date | 2012-02-19 | |
| P1433 | published in | International Journal of Cell Biology | Q26842205 |
| P1476 | title | KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts | |
| P478 | volume | 2012 |
| Q30152630 | A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling |
| Q37671291 | Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo. |
| Q35237492 | Chromatinization of the KSHV Genome During the KSHV Life Cycle |
| Q59351136 | Contemporary Ribonomics Methods for Viral microRNA Target Analysis |
| Q38610039 | Herpesviruses shape tumour microenvironment through exosomal transfer of viral microRNAs |
| Q37376368 | Involvement of eukaryotic small RNA pathways in host defense and viral pathogenesis |
| Q34774797 | KSHV LANA--the master regulator of KSHV latency |
| Q28080937 | KSHV reactivation and novel implications of protein isomerization on lytic switch control |
| Q34257830 | Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells |
| Q40348397 | Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNAs promote matrix metalloproteinases (MMPs) expression and pro-angiogenic cytokine secretion in endothelial cells. |
| Q54229820 | Micro RNAs from DNA Viruses are Found Widely in Plasma in a Large Observational Human Population. |
| Q26752599 | Next-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Biology |
| Q37488961 | Quantitative Proteomic Approach for MicroRNA Target Prediction Based on 18O/16O Labeling |
| Q54216766 | Regulation of virus-associated lymphoma growth and gene expression by bacterial quorum sensing molecules. |
| Q34580878 | Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis |
| Q58766247 | The Diverse Roles of microRNAs at the Host⁻Virus Interface |
| Q26748350 | The Role of microRNAs in the Pathogenesis of Herpesvirus Infection |
| Q38108700 | The chromatin landscape of Kaposi's sarcoma-associated herpesvirus |
| Q37593352 | Viral microRNAs Target a Gene Network, Inhibit STAT Activation, and Suppress Interferon Responses |
Search more.